The culture of volunteerism is a fundamental part of the Novartis corporate ethos. Here’s a snapshot of our efforts over the years.

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

A lung cancer researcher describes her journey toward a career in science at Novartis.

Meet a Senior Medical Director at Novartis who is part of our new “Women in Science” series

Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.